Connection
Allen Cohn to Anilides
This is a "connection" page, showing publications Allen Cohn has written about Anilides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.123 |
|
|
|
-
Kelley RK, Verslype C, Cohn AL, Yang TS, Su WC, Burris H, Braiteh F, Vogelzang N, Spira A, Foster P, Lee Y, Van Cutsem E. Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study. Ann Oncol. 2017 03 01; 28(3):528-534.
Score: 0.123